Shares of Genesis Healthcare Inc. (NYSE:GEN) have been assigned a consensus recommendation of “Hold” from the five analysts that are currently covering the firm. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $2.52.

Separately, Bank of America Corp. set a $1.80 target price on shares of Genesis Healthcare and gave the company a “sell” rating in a report on Monday, September 19th.

Several large investors have recently made changes to their positions in GEN. Alliancebernstein L.P. increased its stake in shares of Genesis Healthcare by 5.8% in the second quarter. Alliancebernstein L.P. now owns 77,126 shares of the company’s stock valued at $137,000 after buying an additional 4,200 shares during the period. BlackRock Investment Management LLC increased its stake in Genesis Healthcare by 10.7% in the second quarter. BlackRock Investment Management LLC now owns 154,153 shares of the company’s stock worth $273,000 after buying an additional 14,865 shares during the period. Geode Capital Management LLC increased its stake in Genesis Healthcare by 1.9% in the first quarter. Geode Capital Management LLC now owns 171,157 shares of the company’s stock worth $397,000 after buying an additional 3,206 shares during the period. Bank of New York Mellon Corp increased its stake in Genesis Healthcare by 17.5% in the second quarter. Bank of New York Mellon Corp now owns 179,071 shares of the company’s stock worth $317,000 after buying an additional 26,629 shares during the period. Finally, Panagora Asset Management Inc. increased its stake in Genesis Healthcare by 14.1% in the second quarter. Panagora Asset Management Inc. now owns 269,631 shares of the company’s stock worth $477,000 after buying an additional 33,311 shares during the period. 8.07% of the stock is owned by institutional investors.

Genesis Healthcare (NYSE:GEN) traded up 1.95% during midday trading on Monday, hitting $2.62. The company’s stock had a trading volume of 56,000 shares. The company’s 50 day moving average price is $2.67 and its 200 day moving average price is $2.21. The firm’s market cap is $235.78 million. Genesis Healthcare has a 12 month low of $1.38 and a 12 month high of $5.75.

Genesis Healthcare (NYSE:GEN) last released its earnings results on Thursday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.01 by $0.27. The firm had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period last year, the firm earned $0.14 EPS. The business’s revenue was up 1.3% on a year-over-year basis. Analysts expect that Genesis Healthcare will post ($1.49) EPS for the current year.

About Genesis Healthcare

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Stock Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related stocks with our FREE daily email newsletter.